Skip to main content
SpringerLink
Log in

Purine and Pyrimidine Metabolism in Man V

Part B: Basic Science Aspects

  • Book
  • © 1986

Overview

Editors:
  1. W. L. Nyhan

    1. University of California, San Diego La Jolla, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. L. F. Thompson

    1. Scripps Clinic and Research Foundation, La Jolla, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. R. W. E. Watts

    1. M. R. C. Clinical Research Center, Harrow, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 195B)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (108 chapters)

  1. Studies with Anti-Metabolites

    1. Synergy of Methotrexate and 6-Mercaptopurine on Cell Growth and Clono- Genicity of Cultured Human T-Lymphoblasts

      • Ronney A. De Abreu, Jos P. M. Bökkerink, Marinka A. H. Bakker, Tilly W. Hulscher, Gerard A. M. de Vaan, Chris H. M. M. de Bruijn et al.
      Pages 129-134

    2. Increased Availability of Phosphoribosyl Pyrophosphate as the Basis for Enhanced 6-Mercaptopurine Incorporation by Methotrexate, in Cultured Human Lymphoblasts

      • Jos P. M. Bökkerink, Ronney A. de Abreu, Jan P. R. M. van Laarhoven, Marinka A. H. Bakker, Tilly W. Hulscher, Egbert D. A. M. Schretlen et al.
      Pages 135-139

    3. Regulation of Deoxyadenosine and Nucleoside Analog Phosphorylation by Human Placental Adenosine Kinase

      • Mary C. Hurley, Bertha Lin, Irving H. Fox
      Pages 141-149

    4. The Biosynthesis of Deoxyguanosine Triphosphate in Herpes Simplex Type-1 Infected Vero Cells Treated with Acyclovir and Hydroxyurea

      • Catherine U. Lambe, Donald J. Nelson, Phillip A. Furman
      Pages 151-156

    5. 5-AZA-2′-Deoxycytidine Synergistic action with Thymidine on Leukemic Cells and Interaction of 5-AZA-dCMP with dCMP Deaminase

      • R. L. Momparler, M. Rossi, J. Bouchard, S. Bartolucci, L. F. Momparler, C. A. Raia et al.
      Pages 157-163

    6. Selection of Purine Nucleoside Analogs based on Multiple Biological and Biochemical Parameters

      • M. Jean Noujaim, George Zombor, J. Frank Henderson
      Pages 165-169

    7. Effect of m-Amsa on the Cellular Pharmacology of Ara-CTP in Human Leukemic Cells During Therapy with High-Dose Ara-C

      • William Plunkett, Michael Keating
      Pages 171-175

    8. 5-Fluoro-5′-Deoxyuridine is an Inhibitor of Uridylate Nucleotidase in L1210 Leukemaemia

      • C. Roobol, G. B. E. De Dobbeleer, J. L. Bernheim
      Pages 177-183

  2. Deoxynucleotide and Nucleoside Toxicity and Metabolism

    1. The Effect of Phosphonoformic acid on Wild type and Mutant S49 Cell Lines

      • Daniel A. Albert, Lorraine J. Gudas
      Pages 185-189

    2. Mechanisms of Deoxyguanosine Toxicity for Human T and B Lymphocytes

      • J. G. M. Scharenberg, L. J. M. Spaapen, G. T. Rijkers, S. K. Wadman, G. E. J. Staal, B. J. M. Zegers
      Pages 191-199

    3. Role of Intracellular Deoxynucleoside Triphosphate Levels in DNA Repair in Human Lymphocytes

      • Amos Cohen
      Pages 201-205

    4. Genetic Analysis of Deoxyadenosine Toxicity in Dividing Human Lymphoblasts

      • Dennis A. Carson, Carlos J. Carrera, Masaru Kubota, D. Bruce Wasson, Taizo Iizasa
      Pages 207-211

    5. Inhibition of 3H-Thymidine Incorporation by Adenosine and Deoxyadenosine in Human Peripheral Lymphocytes and Malignant Lymphoid Cell Lines

      • P. M. van der Krann, P. M. van Zandvoort, R. A. De Abreu, J. A. J. M. Bakkeren, J. P. R. M. van Laarhoven, C. H. M. M. de Bruijn
      Pages 213-219

    6. S-Adenosylmethionine Metabolism as a Target for Adenosine Toxicity

      • E. Olavi Kajander, Masaru Kubota, Eric H. Willis, Dennis A. Carson
      Pages 221-226

    7. Ethanol Induced Nucleotide Catabolism in Mouse T Lymphoblastoid Cells in Vitro

      • Jerzy Barankiewicz, Amos Cohen
      Pages 227-230

    8. Increased Level of Ribonucleotide Reductase in Deoxyadenosine Resistant Adenosine Deaminase Deficient Human Histiocytic Lymphoma Cells

      • Yvonne Dahbo, Dennis Carson, Staffan Eriksson
      Pages 231-234

    9. Inhibition of T Cell Cytotoxicity by Cyclosporine (CSA), Adenosine (ADO) and an Inhibitor of Adenosine Deaminase (ADA)

      • Caliann T. Lum, Stephen R. Jennings, Frederick J. Wanner, Satvir S. Tevethia
      Pages 235-238

  3. Enzymes

    1. Mechanism of Urate Production by Guinea-Pig Ileum

      • D. R. Webster, G. D. Boston, D. M. Paton
      Pages 239-243

    2. In Vitro Degradation of Pyrimidine Bases: Studies of Rat Liver Dihydropyrimidine Dehydrogenase

      • Mendel Tuchman, Margaret L. Ramnaraine, Robert F. O’Dea
      Pages 245-248

    3. Regulation of Enzymes by Ligand Induced Change in Polymerization

      • Thomas W. Traut, Nancy Cheng, Margaret M. Matthews
      Pages 249-254
Back to top

Keywords

About this book

The Fifth International Symposium on Human Purine and Pyrimidine Metabolism was held in San Diego, California (U. S. A. ) in July and August of 1985. Previous meetings in this series were held in Tel Aviv (Israel), Baden (Austria), Madrid (Spain) and Maastricht (The Netherlands). The proceedings of each of these meetings were published by Plenum. The next meeting will be in Japan. This Symposium differed from those that went before in that it per­ mitted us to honor Dr. J. E. Seegmiller, Professor of Medicine at the University of California San Diego, for his many contributions to our understanding of purine metabolism in man. This publication is dedicated as a Festschrift to Jay. Dr. Richard W. E. Watts delivered the keynote address outlining in scholarly fashion the history of Dr. Seegmiller's accomplishments in research on purine metabolism and the great number of currently active scientists in this field who have worked with him. This address is published as the first contribution to Volume I. Dr. Dewitt Stetten, Jr. , was scheduled to be the speaker at our banquet. Unfortunate­ ly, he could not be with us. Dr. Seegmiller has written an appreciation of Dr. Stetten and his contributions to our field, and this has been pub­ lished following Dr. Watts' paper. The growth of knowledge in purine and pyrimidine metabolism continues to be exponential. The variety of subjects included in these volumes is impressive.

Editors and Affiliations

  • University of California, San Diego La Jolla, USA

    W. L. Nyhan

  • Scripps Clinic and Research Foundation, La Jolla, USA

    L. F. Thompson

  • M. R. C. Clinical Research Center, Harrow, UK

    R. W. E. Watts

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation